ArticleThe Journal of general virology2026
Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant.
Andris Dislers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.